Introducing Slate 2.0: Make Discovery More Inevitable and Less Accidental. See What’s New

How to Connect Scientific Data to Copilot with MCP

Microsoft Copilot is already used by R&D teams for information discovery and everyday knowledge work. It can summarize documents, answer questions, and help users navigate large volumes of information. But R&D decisions need answers grounded in current scientific papers, patents, experimental findings, and sources they can verify. That becomes especially important during stage-gate reviews, regulatory […]

PDRN and Sodium DNA/RNA: Neurocosmetics’ Shift to Nucleic Acid Actives

Botanical cortisol-blocking has helped shape the first wave of neurocosmetics. Recent patent activity suggests the next wave may look very different. Shanghai Lebao Daily Chemical is exploring an anti-wrinkle composition that combines DNA sodium/PDRN with RNA as a neurotransmitter inhibitor. Shenzhen Readline Biotech is developing peptide-based compositions aimed at regulating neurotransmitter activity for anti-aging. Botanical […]

5 Hidden White Spaces in Neuro-Active Pathways Beyond Cortisol

Publication activity around cortisol-blocking innovations accelerated by 233% between 2024 and 2026, rising from 6 to 20 publications annually.  Companies such as Bloomage Biotechnology and Shanghai Zhizhen Zhichen Technology have expanded the landscape using familiar actives such as GABA and ectoine to inhibit 11β-HSD1, the enzyme responsible for converting cortisone into cortisol. For cosmetic R&D […]

Cyclic Peptides vs Botanical Extracts in Neurocosmetics: Where Is the IP Concentrated?

Botanical stress-relief formulations are getting crowded fast, while cyclic peptides are moving into a much more concentrated and defensible IP space. Between 2023-2024 and 2025-2026, botanical stress-relief neurocosmetic publications jumped 233%, from 6 to 20 annually. Rather than signaling a fresh opportunity, this surge suggests that enzymatic cortisol-blocking is quickly becoming a baseline market requirement. […]

Top 5 R&D Bottlenecks & How to Overcome Them 

Funding, specialist expertise, and laboratory capacity remain critical bottlenecks for R&D teams. However, many delays also arise from how technical information is found, shared, evaluated, and converted into decisions. In the 2026 Innovation Research Interchange survey, 48% of R&D leaders expected their budgets to increase during the year. But additional funding creates value only when […]

Slate vs. Perplexity for Enterprise R&D: Which Platform Fits Which Research Workflow?

R&D teams are constantly facing a strange decision: whether to research with a general-purpose AI answer engine or a domain-specific R&D intelligence platform? Now in 2026, it narrows down to two names – Perplexity and SLATE. Ask which one is better, and you’re already asking the wrong question. The right one is: better at what, […]

Why Most Technology Scouting Fails: 8 Mistakes R&D Teams Need to Fix 

Technology scouting is supposed to give R&D teams a head start from spotting emerging technologies to solving technical problems. Yet a lot of scouting projects land in the same place: a deck of patents, papers, companies & technology concepts but no clear decision.  Companies have more research, patents, funding, and external innovation available to them […]

Functional Hydration’s Next M&A Wave: What PepsiCo, Unilever, and Celsius Are Really Buying 

Hydration used to be simple. Replace fluids. Add electrolytes. Maybe add sugar for faster absorption. That playbook is now changing. The next version of hydration is becoming a platform for gut health, cognition, energy, recovery, beauty, metabolic support, and eventually personalization. That’s why large beverage companies are no longer looking at hydration brands only as […]